Lv3
256 积分 2023-07-20 加入
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing
13分钟前
已完结
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
17分钟前
已完结
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial
24分钟前
已完结
Understanding and targeting resistance mechanisms in NSCLC
28分钟前
已完结
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2个月前
已完结
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2个月前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
2个月前
已完结
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2个月前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
2个月前
已完结
Relationship of Field Dependence/Independence to Adaption-Innovation in Alcoholics
2个月前
已完结